rhTPO (recombinant human thrombopoietin)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for rhTPO (recombinant human thrombopoietin), covering 2019-09-13 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients. [Phase 2]